Published December, 2021
By Hui Quan, Gang Li, Bruce Binkowitz, William Wang and Josh Chen
Publisher: Taylor & Francis (CRC Press)
Rating: 1.00
Availability: Available

This book contains chapters providing interpretations of principles in ICH E17 and new ideas of implementing MRCTs. Authors are from different regions, and from academia and industry. This book will be of particular interest to biostatisticians working in late stage clinical development of medical products.

---

Published December, 2021
By Nicola Veronese and Jacopo Demurtas
Publisher: Springer (Springer Nature Switzerland AG)
Rating: 1.00
Availability: Available

---

Published December, 2021
By Carsten Dormann
Publisher: Springer (Springer Nature Switzerland AG)
Rating: 1.00
Availability: Available

Environmental Data Analysis is an introductory statistics textbook for environmental science.

---

Published December, 2021
By Rodrick Wallace and Deborah Wallace
Publisher: Springer (Springer Nature Switzerland AG)
Rating: 1.00
Availability: Available

---

Published December, 2021
By Ray M. Merrill
Publisher: Class Publishing (Jones & Bartlett Publishers)
Rating: 1.00
Availability: Available

---

Published December, 2021
By Chunxiang Cao, Min Xu, Patcharin Kamsing, Sornkitja Boonprong, Peera Yomwan and Apitach Saokarn
Publisher: Springer (Springer Verlag, Singapore)
Rating: 1.00
Availability: Available

This book introduces flood inundation area and flood risks assessment based on a comprehensive monitoring system using remote sensing and geographic information system technologies.

---

Published December, 2021
By Peter F. Thall, Ying Yuan and Hoang Q. Nguyen
Publisher: Taylor & Francis
Rating: 1.00
Availability: Available

This book is the first to focus on Bayesian phase I-II clinical trials. It describes many problems with the conventional phase I-phase II paradigm and covers a large number of modern Bayesian phase I-II clinical trial designs.

---

Published December, 2021
By Emmanuel Lesaffre, Gianluca Baio and Bruno Boulanger
Publisher: Taylor & Francis
Rating: 1.00
Availability: Available

Bayesian methods have emerged as the driving force for methodological development in drug development. This edited book provides broad coverage of Bayesian methods in pharmaceutical research. The book includes contributions from some of the leading researchers in the field, and has been edited to ensure consistency in level and style.

---

Published December, 2021
By Nusrat Rabbee
Publisher: Taylor & Francis
Rating: 1.00
Availability: Available

---

Published December, 2021
By Craig Mallinckrodt, Geert Molenberghs, Bohdana Ratitch and Ilya Lipkovich
Publisher: Taylor & Francis
Rating: 1.00
Availability: Available

This book will use the new guidance as a framework for developing and implementing comprehensive analysis plans for clinical trials that support the development and approval of medical interventions.

---